Selank — - 10mg

Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is an analogue of the endogenous immunomodulatory peptide tuftsin, which is naturally cleaved from the Fc fragment of the IgG heavy chain. The structure of Selank is identical to tuftsin (Thr-Lys-Pro-Arg) but features a stabilizing Pro-Gly-Pro sequence at its C-terminus. This modification was designed to increase the peptide's metabolic stability and prolong its biological activity in research settings, making it a more robust tool for in vitro and in vivo investigations compared to its parent peptide.

Developed for its potential pleiotropic effects on the central nervous and immune systems, Selank has become a subject of significant interest in neuroscience and psychopharmacology research. Its primary area of investigation involves its anxiolytic-like and nootropic properties, which have been observed in various preclinical models. Unlike classical benzodiazepines, which primarily act on GABA-A receptors and can induce sedation and cognitive impairment, Selank is studied for its capacity to modulate anxiety-related behaviors through distinct neurochemical pathways. This unique profile allows researchers to explore the mechanisms of anxiety and cognition without the confounding variables introduced by traditional sedative-hypnotics.

In laboratory studies, Selank is investigated for its influence on monoamine neurotransmitter systems, neurotrophic factor expression, and cytokine regulation. Its dual action on both the nervous and immune systems makes it a valuable compound for exploring the intricate neuro-immune axis, particularly how immune signaling can impact mood, stress resilience, and cognitive processes. Researchers utilizing Selank are often focused on elucidating the molecular underpinnings of anxiety disorders, stress adaptation, and memory formation. Nexa Peptides provides high-purity, lyophilized Selank exclusively for laboratory research purposes, ensuring consistent and reliable results for scientific inquiry. This product is not intended for human consumption.

The mechanism of action for Selank is complex and multifactorial, reflecting its role as a regulatory peptide rather than a classical receptor agonist or antagonist. Its effects are primarily mediated through the modulation of several key biological systems within the central nervous system and its interface with the immune system. A core aspect of its activity involves the regulation of monoamine neurotransmitters. In preclinical models, Selank has been shown to influence the turnover of serotonin in brain regions critical for mood and anxiety, such as the hypothalamus and frontal cortex. It appears to normalize the concentration of serotonin and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), particularly under conditions of stress, suggesting a homeostatic or stabilizing effect on serotonergic pathways.

Another significant mechanism involves the upregulation of neurotrophic factors, most notably brain-derived neurotrophic factor (BDNF). In vitro and in vivo studies have demonstrated that Selank administration can increase the expression of BDNF mRNA in the hippocampus, a brain region integral to learning, memory, and emotional regulation. BDNF is essential for neuronal survival, synaptogenesis, and synaptic plasticity. By enhancing BDNF levels, Selank is hypothesized to support the neural architecture required for robust cognitive function and emotional resilience, providing a molecular basis for its investigated nootropic and anxiolytic properties.

As an analogue of tuftsin, Selank retains immunomodulatory functions. It has been observed to modulate the expression of pro-inflammatory and anti-inflammatory cytokines, including Interleukin-6 (IL-6). This action is critical for research into the neuro-immune axis, where chronic stress and anxiety are often associated with a pro-inflammatory state. By influencing cytokine balance, Selank may help researchers understand how to mitigate the central nervous system effects of peripheral inflammation. This mechanism connects its anxiolytic potential with its immunoregulatory capabilities, offering a tool to study the interplay between psychological stress and immune response.

Furthermore, some evidence suggests that Selank may exert its effects by inhibiting the activity of enkephalinases, the enzymes responsible for degrading endogenous opioid peptides like enkephalins. By preventing the breakdown of these peptides, Selank could potentiate their natural anxiolytic and stress-protective actions without directly binding to opioid receptors. This indirect mechanism would be consistent with the observation that Selank does not exhibit the addictive potential or other adverse effects associated with direct opioid agonists. Collectively, these pathways illustrate that Selank functions as a sophisticated neuromodulator, fine-tuning multiple systems to promote neural homeostasis and resilience in experimental models. For Research Use Only.

Selank is a valuable tool in a range of laboratory research applications, primarily centered on neuroscience, psychopharmacology, and immunology. Its most prominent area of investigation is in preclinical models of anxiety and stress. Researchers utilize Selank in rodent models subjected to paradigms such as the elevated plus-maze, light-dark box, and social interaction tests to assess its anxiolytic-like potential. These studies aim to characterize its ability to reduce anxiety-related behaviors without inducing the sedation, amnesia, or motor impairment commonly associated with benzodiazepine-class compounds. This makes it a useful compound for isolating and studying the neurobiological circuits of anxiety.

In the field of cognitive neuroscience, Selank is studied for its nootropic or cognitive-enhancing effects. Laboratory investigations often evaluate its impact on learning, memory consolidation, and attention, particularly in models where cognitive function is compromised by stress, aging, or chemical insult. Standardized tests like the Morris water maze, passive avoidance tasks, and object recognition tests are employed to quantify changes in cognitive performance. These studies frequently correlate behavioral outcomes with molecular changes, such as the expression of BDNF in the hippocampus, to elucidate the underlying mechanisms of cognitive enhancement.

Given its structural relationship to tuftsin, Selank is also applied in research exploring the neuro-immune axis. Scientists investigate its effects on cytokine profiles, microglial activation, and T-cell differentiation in both central and peripheral systems. This line of research is critical for understanding conditions where immune dysregulation and neuropsychiatric symptoms coexist, such as in models of neuroinflammation or stress-induced immunosuppression. By studying how Selank modulates these pathways, researchers can gain insight into the bidirectional communication between the brain and the immune system.

Additionally, Selank is utilized in studies on neuroprotection and neuronal recovery. In vitro cell culture models and in vivo models of neurological injury, such as cerebral ischemia, are used to examine whether Selank can protect neurons from damage and support functional recovery. These investigations focus on its ability to modulate inflammatory responses, reduce oxidative stress, and promote the expression of neurotrophic factors that support cell survival and plasticity. All applications of Selank are strictly for in vitro and in vivo laboratory research and are not intended for any form of human use. For Research Use Only.